Mauna Kea Technologies SA (EPA:ALMKT)
France · Delayed Price · Currency is EUR | Market Cap | 28.08M +275.8% |
| Revenue (ttm) | 8.91M +5.9% |
| Net Income | 10.77M |
| EPS | 0.10 |
| Shares Out | 192.84M |
| PE Ratio | 1.52 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 250,699 |
| Open | 0.1450 |
| Previous Close | 0.1456 |
| Day's Range | 0.1410 - 0.1452 |
| 52-Week Range | 0.0692 - 0.2315 |
| Beta | 0.94 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 8, 2026 |
About Mauna Kea Technologies
Mauna Kea Technologies SA manufactures and sells medical devices in Europe, Middle East, Africa, the United States, Canada, and Asia. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables physicians to monitor disease progression over time, assess reactions as they occur, classify areas of uncertainty, and guide surgical procedures, and help diagnose and treat patients. The company was incorporated in ... [Read more]
Financial Performance
Financial StatementsNews
Mauna Kea Technologies Slides: Q2 2026
Mauna Kea Technologies has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 21, 2026.
Mauna Kea Technologies Earnings release: Q2 2026
Mauna Kea Technologies released its Q2 2026 earnings on July 21, 2026, summarizing the period's financial results.
Mauna Kea Technologies Slides: Corporate presentation
Mauna Kea Technologies has posted slides in relation to its latest quarterly earnings report, which was published on June 15, 2026.
Mauna Kea Technologies Slides: Corporate presentation
Mauna Kea Technologies has posted slides in relation to its latest quarterly earnings report, which was published on May 4, 2026.
Mauna Kea Technologies Earnings Call Transcript: H2 2025
2025 saw accelerated sales growth, a major debt reduction, and a return to net profitability, with strong U.S. and international momentum. The company is on track for EBITDA profitability by 2027 and continues to expand its MedTech platform and commercial reach.
Mauna Kea Technologies Earnings release: H2 2025
Mauna Kea Technologies released its H2 2025 earnings on April 22, 2026, summarizing the period's financial results.
Mauna Kea Technologies Slides: H2 2025
Mauna Kea Technologies has posted slides in relation to its H2 2025 quarterly earnings report, which was published on April 22, 2026.
Mauna Kea Technologies Annual report: H2 2025
Mauna Kea Technologies has published its H2 2025 annual report on April 22, 2026.
Mauna Kea Technologies Reports FY 2025 Financial Results: Comprehensive Debt Restructuring and Reaccelerating Organic Growth Mark a Transformative 2025
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p...
Mauna Kea Technologies Reports Strong Q1 2026 Core Sales Growth
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p...
Mauna Kea Technologies Earnings release: Q1 2026
Mauna Kea Technologies released its Q1 2026 earnings on April 15, 2026, summarizing the period's financial results.
Mauna Kea Technologies Slides: Q1 2026
Mauna Kea Technologies has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 15, 2026.
Mauna Kea Technologies Announces CE MDR Certification For Cellvizio® and Its Associated Probes • news
A major regulatory milestone in the European commercial expansion strategy
Mauna Kea Technologies Earnings release: Q4 2025
Mauna Kea Technologies released its Q4 2025 earnings on January 15, 2026, summarizing the period's financial results.
Mauna Kea Technologies Earnings Call Transcript: H1 2025
A major debt restructuring and planned capital increase position the company for renewed growth, with strong US sales momentum and profitability targeted for 2027. Commercial expansion and new market entries are expected to drive further value.
Mauna Kea Technologies Earnings release: H1 2025
Mauna Kea Technologies released its H1 2025 earnings on October 6, 2025, summarizing the period's financial results.
Mauna Kea Technologies Quarterly report: H1 2025
Mauna Kea Technologies has published its H1 2025 quarterly earnings report on October 6, 2025.
Mauna Kea Technologies Reaches a Key Milestone in Its Financial Restructuring • news
Mauna Kea Technologies Announces 2025 Half-Year Results
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p...